Evaluation of Risk Factors for Cataract Types in a Competing Risks Framework

REFERENCES

• World Health Organization. Magnitude and causes of visual impairment, Accessed February 11, 2009 at www.who.int/mediacentre/factsheets/fs282/en Fact Sheet No. 282. November 2004
   Google Scholar
• Mohan M, Sperduto R D, Angra S K, Milton R C, Mathur R L, Underwood B A, Pandya J N, Chhabra V K, Vajpayee R B. India-US Case-Control Study of Age-Related Cataracts. India-US Case-Control Study Group. Arch Ophthalmol 1989; 107: 670–676
   PubMed Web of Science ®Google Scholar
• Leske M C, Chylack L T, Jr., Wu S Y. The Lens Opacities Case-Control Study. Risk factors for cataract. Arch Ophthalmol 1991; 109: 244–251
   PubMed Web of Science ®Google Scholar
• Age-Related E ye. Disease Study Group. Risk factors associated with age-related nuclear and cortical cataract: A case-control study in the Age-Related Eye Disease Study, AREDS Report No. 5. Ophthalmology. 2001; 108: 1400–1408
   PubMedGoogle Scholar
• Klein B EK, Klein R, Lee K E, Meuer S M. Socioeconomic and lifestyle factors and the 10-year incidence of age-related cataract. Am J Ophthalmol 2003; 136: 506–512
   PubMed Web of Science ®Google Scholar
• Klein B EK, Klein R, Lee K E. Diabetes, cardiovascular disease, selected cardiovascular risk factors, and the 5-year incidence of age-related cataract and progression of lens opacities: The Beaver Dam Eye Study. Am J Ophthalmol 1998; 126: 782–790
   PubMed Web of Science ®Google Scholar
• Klein B EK, Klein R, Lee K E. Incidence of age-related cataract: the Beaver Dam Eye Study. Arch Ophthalmol 1998; 116: 219–225
   PubMedGoogle Scholar
• Leske M C, Wu S Y, Nemesure B, Hennis A. Risk factors for incident nuclear opacities. Ophthalmology 2002; 109: 1303–1308
   PubMed Web of Science ®Google Scholar
• Hennis A, Wu S-Y, Nemesure B, Leske M C. Risk factors for incident cortical and posterior subcapsular lens opacities in the Barbados Eye Studies. Arch Ophthalmol 2004; 122: 525–530
   PubMedGoogle Scholar
• Leske M C, Wu S-Y, Nemesure B, Li X, Hennis A, Connell A M. Incidence and progression of lens opacities in the Barbados Eye Studies. Ophthalmology. 2000; 107: 1267–1273
   PubMed Web of Science ®Google Scholar
• Hiller R, Sperduto R D, Ederer F. Epidemiologic associations with nuclear, cortical, and posterior subcapsular cataracts. Am J Epidemiol 1986; 124: 916–925
   PubMed Web of Science ®Google Scholar
• Hiller R, Sperduto R D, Podgor M J, Wilson P W, Feris F L, III, Colton T, D'Agostino R B, Roseman M J, Stockman M E, Milton R C. Cigarette smoking and the risk of development of lens opacities: The Framingham Study. Arch Ophthalmol 1997; 115: 1113–1118
   PubMed Web of Science ®Google Scholar
• Hiller R, Podgor M J, Sperduto R D, Nowroozi L, Wilson P WF, D'Agostino R B, Colton T. A longitudinal study of body mass index and lens opacities: The Framingham Studies. Ophthalmology. 1998; 105: 1244–1250
   PubMed Web of Science ®Google Scholar
• Nirmalan P K, Robin A J, Katz J, Tielsch J M, Thulasiraj R D, Krishnadas R, Ramakrishnan R. Risk factors for age related cataract in a rural population of southern India: The Aravind Comprehensive Eye Study. Br J Ophthalmol 2004; 88: 989–994
   PubMed Web of Science ®Google Scholar
• Cumming R G, Mitchell P. Alcohol, smoking and cataracts: The Blue Mountains Eye Study. Arch Ophthalmol 1997; 115: 1296–1303
   PubMed Web of Science ®Google Scholar
• Kuzniarz M, Mitchell P, Cumming R G, Flood V M. Use of vitamin supplements and cataract: The Blue Mountains Eye Study. Am J Ophthalmol. 2001; 132: 19–26
   PubMed Web of Science ®Google Scholar
• Kuang T-M, Tsai S-Y, Hsu W-M, Cheng C-Y, Liu J-H, Chou P. Body mass index and age-related cataract: The Shihpai Eye Study. Arch Ophthalmol. 2005; 123: 1109–1114
   PubMed Web of Science ®Google Scholar
• Leske M C, Chylack L T, Jr., He Q, Wu S Y, Schoenfeld E, Friend J, Wolfe J. Antioxidant vitamins and nuclear opacities: The longitudinal study of cataract. Ophthalmology. 1998; 105: 831–836
   PubMed Web of Science ®Google Scholar
• Hankinson S E, Willett W C, Colditz G A, Seddon J M, Rosner B, Speizer F E, Stampfer M J. A prospective study of cigarette smoking and risk of cataract surgery in women. JAMA 1992; 268: 994–008
   PubMed Web of Science ®Google Scholar
• Weintraub J M, Willett W C, Rosner B, Colditz G A, Seddon J M, Hankinson S E. A prospective study of the relationship between body mass index and cataract extraction among women and men. Intern J Obesity 2002; 26: 1588–1595
   PubMed Web of Science ®Google Scholar
• Mukesh B N, Le A, Dimitrov P N, Ahmed S, Taylor H R, McCarty C A. Development of cataract and associated risk factors: The Visual Impairment Project. Arch Ophthalmol 2006; 124: 79–85
   PubMedGoogle Scholar
• Sperduto R D, Hu T S, Milton R C, Zhao J L, Everett D F, Cheng Q F, Blot W H, Bing L, Taylor P R, Li J Y, et al. The Linxian cataract studies: Two nutrition intervention trials. Arch Ophthalmol. 1993; 111: 1246–1253
   PubMed Web of Science ®Google Scholar
• Age-Related Eye Disease Study Research Group. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E and beta carotene for age-related cataract and vision loss: AREDS report no. 9. Arch Ophthalmol 2001; 119: 1439–1452
   PubMed Web of Science ®Google Scholar
• Christen W G, Manson J E, Seddon J M, Glynn R J, Buring J E, Rosner B, Hennekens C H. A prospective study of cigarette smoking and risk of cataract. JAMA 1992; 268: 989–993
   PubMed Web of Science ®Google Scholar
• Seddon J M, Christen W G, Manson J E, LaMotte F S, Glynn R J, Buring J E, Hennekens C H. The use of vitamin supplements and the risk of cataract among US male physicians. Am J Pub Health 1994; 84: 788–792
   PubMed Web of Science ®Google Scholar
• Glynn R J, Christen W G, Manson J E, Bernheimer J, Hennekens C H. Body mass index: An independent predictor of cataract. Arch Ophthalmol 1995; 113: 1131–1137
   PubMed Web of Science ®Google Scholar
• Schaumberg D A, Glynn R J, Christen W G, Ajani U A, Stürmer T, Hennekens C H. A prospective study of blood pressure and risk of cataract in men. Ann Epidemiol 2001; 11: 104–110
   PubMed Web of Science ®Google Scholar
• Christen W G, Manson J E, Glynn R J, Gaziano J M, Sperduto R D, Buring J E, Hennekens C H. A randomized trial of beta carotene and age-related cataract in US physicians. Arch Ophthalmol. 2003; 121: 372–378
   PubMedGoogle Scholar
• Marshall R J, Chisholm E M. Hypothesis testing in the polychotomous logistic regression model with an application to detecting gastrointestinal cancer. Stat Med. 1985; 4: 337–344
   PubMedGoogle Scholar
• Glynn R J, Rosner B. Methods to evaluate risks for composite end points and their individual components. J Clin Epidemiol 2004; 57: 113–122
   PubMedGoogle Scholar
• Lunn M, McNeil D. Applying Cox regression to competing risks. Biometrics. 1995; 51: 524–532
   PubMed Web of Science ®Google Scholar
• Glynn R J, Rosner B. Comparison of risk factors for the competing risks of coronary heart disease, stroke and venous thromboembolism. Am J Epidemiol 2005; 162: 975–982
   PubMed Web of Science ®Google Scholar
• Lee E W, Wei L J, Amato D J. Cox-type regression analysis for large numbers of small groups of correlated failure time observations. Survival Analysis: State of the Art., J P Klein, P K Goel. Kluwer Academic Publishers, DordrechtThe Netherlands 1992; 237–247
   Google Scholar
• Wei L J, Lin D Y, Weissfeld L. Regression analysis of multivariate incomplete failure time data by modeling marginal distributions. J Am Statist Assoc. 1989; 84: 1065–1073
   Web of Science ®Google Scholar
• The Steering Committee of the Physicians' Health Study Research Group, Belanger C, Buring J E, Cook N, Eberlein K, Goldhaber S Z, Gordon D, Hennekens C H, Chairman, Mayrent S L, Peto R, Rosner B, Stampfer M, Stubblefield F, Willett W. Final report on the aspirin component of the ongoing Physicians' Health Study. N Engl J Med. 1989; 321: 129–135
   PubMed Web of Science ®Google Scholar
• Hennekens C H, Buring J E, Manson J E, Stampfer M, Rosner B, Cook N R, Belanger C, LaMotte F, Gaziano J M, Ridker P M, Willett W, Peto R. Lack of effect of long-term supplementation with beta-carotene on the incidence of malignant neoplasms and cardiovascular disease. N Eng J Med. 1996; 334: 1145–1149
   PubMed Web of Science ®Google Scholar
• Gaynor J J, Feuer E J, Tan C C, Wu D H, Little C R, Straus D J, Clarkson B D, Brennan M F. On the use of cause-specific failure and conditional failure probabilities: Examples from clinical oncology data. J Am Statist Assoc 1993; 88: 400–409
   Web of Science ®Google Scholar
• Pepe M S, Mori M. Kaplan-Meier, marginal or conditional probability curves in summarizing competing risks failure time data?. Stat Med. 1993; 12: 548–555
   Google Scholar
• Korn E L, Graubard B I, Midthune D. Time-to-event analysis of longitudinal follow-up of a survey: Choice of the time-scale. Am J Epidemiol 1997; 145: 72–80
   PubMed Web of Science ®Google Scholar
• Therneau T M, Grambsch P M. Modeling Survival Data: Extending the Cox Model. Springer-Verlag, New York 2000; 44–47
   Google Scholar
• Rotnitzky A, Jewell N A. Hypothesis testing of regression parameters in semiparametric generalized linear models for cluster correlated data. Biometrika 1990; 77: 485–497
   Web of Science ®Google Scholar
• Schoenfeld D. Partial residuals for the proportional hazards regression model. Biometrika 1982; 69: 239–241
   Web of Science ®Google Scholar
• Beyersmann J, Dettenkofer M, Bertz H, Shumacher M. A competing risks analysis of bloodstream infection after stem-cell transplantation using subdistribution hazards and cause-specific hazards. Stat Med 2007; 26: 5360–5369
   PubMed Web of Science ®Google Scholar
• Putter H, Fiocco M, Geskus R B. Tutorial in biostatistics: competing risks and multi-state models. Stat Med 2007; 26: 2389–2430
   PubMed Web of Science ®Google Scholar